SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-018883
Filing Date
2018-08-02
Accepted
2018-08-02 16:03:26
Documents
46
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ttph-10q_20180630.htm 10-Q 1565093
2 EX-31.1 ttph-ex311_9.htm EX-31.1 17281
3 EX-31.2 ttph-ex312_6.htm EX-31.2 17539
4 EX-32.1 ttph-ex321_7.htm EX-32.1 6204
5 EX-32.2 ttph-ex322_8.htm EX-32.2 6489
  Complete submission text file 0001564590-18-018883.txt   4323639

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ttph-20180630.xml EX-101.INS 729154
7 XBRL TAXONOMY EXTENSION SCHEMA ttph-20180630.xsd EX-101.SCH 34297
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttph-20180630_cal.xml EX-101.CAL 24940
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttph-20180630_def.xml EX-101.DEF 105740
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttph-20180630_lab.xml EX-101.LAB 261976
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttph-20180630_pre.xml EX-101.PRE 188520
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35837 | Film No.: 18988201
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1